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Frataxin deficiency is the primary cause of Friedreich ataxia (FRDA), an autosomal recessive cardiodegenerative
and neurodegenerative disease. Frataxin is a nuclear-encoded mitochondrial protein that is widely conserved among
eukaryotes. Genetic inactivation of the yeast frataxin homologue (Yfh1p) results in mitochondrial iron accumulation
and hypersensitivity to oxidative stress. Increased iron deposition and evidence of oxidative damage have also been
observed in cardiac tissue and cultured fibroblasts from patients with FRDA. These findings indicate that frataxin
is essential for mitochondrial iron homeostasis and protection from iron-induced formation of free radicals. The
functional mechanism of frataxin, however, is still unknown.We have expressed the mature form of Yfh1p (mYfh1p)
in Escherichia coli and have analyzed its function in vitro. Isolated mYfh1p is a soluble monomer (13,783 Da)
that contains no iron and shows no significant tendency to self-associate. Aerobic addition of ferrous iron tomYfh1p
results in assembly of regular spherical multimers with a molecular mass of ∼1.1 MDa (megadaltons) and a diameter
of nm. Each multimer consists of ∼60 subunits and can sequester 13,000 atoms of iron. Titration of mYfh1p13 2
with increasing iron concentrations supports a stepwise mechanism of multimer assembly. Sequential addition of
an iron chelator and a reducing agent results in quantitative iron release with concomitant disassembly of the
multimer, indicating that mYfh1p sequesters iron in an available form. In yeast mitochondria, native mYfh1p exists
as monomer and a higher-order species with a molecular weight 1600,000. After addition of 55Fe to the medium,
immunoprecipitates of this species contain 116 atoms of 55Fe per molecule of mYfh1p. We propose that iron-
dependent self-assembly of recombinant mYfh1p reflects a physiological role for frataxin in mitochondrial iron
sequestration and bioavailability.
Introduction
Iron is essential for many cellular functions, but free
iron is extremely insoluble and is highly toxic at phys-
iological pH under aerobic conditions (de Silva et al.
1996). To overcome these obstacles, bacterial and eu-
karyotic cells have adopted various mechanisms for
the acquisition and intracellular storage of iron (de
Silva et al. 1996; Harrison and Arosio 1996). There
are no known mechanisms for iron management in-
side mitochondria, in spite of the fact that iron is
required for heme and iron-sulfur cluster biosynthesis,
and uncomplexed iron can react with hydrogen per-
oxide, a by-product of respiration, and generate
highly toxic hydroxyl radicals (Wallace and Melov
1998). Although most iron is probably incorporated
into heme and iron-sulfur clusters immediately after
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crossing the inner mitochondrial membrane, it seems
logical that mitochondria should have some mecha-
nism to chaperone and/or sequester uncomplexed iron
and to release it when needed. The mitochondrial pro-
tein frataxin (Campuzano et al. 1997; Koutnikova et
al. 1997) is a potential candidate to fulfill this func-
tion. The results of recent studies have shown that
yeast frataxin (Yfh1p) is required for mitochondrial
iron efflux (Radisky et al. 1999) and that lack of
Yfh1p results in mitochondrial iron overload, which
in turn leads to increased sensitivity to oxidant stress
and loss of mitochondrial function (Babcock et al.
1997; Foury and Cazzalini 1997). A deficiency of hu-
man frataxin is responsible for Friedreich ataxia
(FRDA [MIM 229300]), an autosomal recessive car-
diodegenerative and neurodegenerative disease (Cam-
puzano et al. 1996). Iron deposits, multiple iron-sul-
fur enzyme deficiencies, and reduced levels of mtDNA
have been observed in cardiac tissue from patients
with FRDA (Lamarche et al. 1980; Rotig et al. 1997;
Bradley et al. 2000). In addition, hypersensitivity to
oxidative stress that responds to iron chelators has
been observed in cultured FRDA fibroblasts (Wong et
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al. 1999). These findings indicate that frataxin is es-
sential for mitochondrial iron homeostasis and for re-
lief from free radical toxicity in yeast and humans as
well. The functional mechanism of frataxin, however,
is unknown. A direct role in iron export across the
inner mitochondrial membrane seems unlikely, in view
of the hydrophilicity of frataxin (Knight et al. 1998;
Branda et al. 1999) and the apparent lack of physical
interaction between frataxin and other mitochondrial
proteins involved in iron movement (Koutnikova et
al. 1998). We have hypothesized that frataxin could
instead serve as a means to sequester mitochondrial
iron and maintain it in a bioavailable form. To begin
to test this hypothesis, we have analyzed the ability
of a recombinant yeast frataxin polypeptide (mYfh1p)
to sequester and release iron in vitro. We describe the
iron-dependent self-assembly of mYfh1p and discuss
its possible implications for frataxin function in vivo.
Material and Methods
Plasmids and Strains
The primers used for the Yfh1p(V60M) construct
were a forward primer including an EcoRI site, a Kozak
sequence (Kozak 1987), and the 5′ end of the YFH1
(GenBank accession number Z74168) coding sequence
(5′-agaattcgccgccaccatgattaagcggtctctcgcaag-3′), and a
reverse primer including codons 54–65 of YFH1, with
a GTTrATG change at codon 60 (5′-acttcttgaggcaccatt-
tgaccatctgtcgagg-3′). The PCR product was coupledwith
a reverse primer including the 3′ end of the YFH1 coding
sequence, a stop codon, and a SalI site (5′-atatatgtcgac-
cttattggcttttagaaatggccttc-3′). The final PCR product
was cloned into pGEM-4 (Promega) and was sequenced
completely, yielding pGEM-YFH1(V60M). The primers
used to generate a PCR product for the mYfh1p ex-
pression construct were a forward primer including an
NdeI site, an ATG codon, and codons 53–62 of YFH1
(5′-tattattacatatggaatcctcgacagatggtcaagttgtgcc-3′), and
a reverse primer including the 3′ end of the YFH1 coding
sequence, a stop codon, and a BamHI site (5′-tatatagga-
tccattattggcttttagaaatggccttctcaac-3′). This product was
cloned into pET24a() (Novagen) downstream of the
T7 promoter and was sequenced completely, yielding
pETYF-1, which was transformed into Escherichia coli
strain BL21(DE3) (Novagen) to produce the BL21
(DE3)[pETYF-1] strain.
Expression and Purification of Recombinant mYfh1p
An overnight culture of BL21(DE3)[pETYF-1] was
inoculated into 500 ml Luria broth containing 30 mg
kanamycin per ml. Cells were grown to an OD600 of
∼0.7, and mYfh1p expression was induced with 0.5
mM isopropyl-b-D-thiogalactopyranoside for 2 h at
37C. Cells (wet weight 4 g) were harvested, washed,
and resuspended in 10 ml of 20 mM Tris-HCl, pH
8.0, 50 mM NaCl (TN50) and were disrupted by son-
ication. After centrifugation at 25,000# g for 20 min
at 4C, the supernatant (total protein 195 mg) was
loaded on an MT20 column packed with Macro-Prep
DEAE (Bio-Rad). The column was washed with 140
ml TN50, and mYfh1p was eluted by a 400-ml linear
gradient from 50–550 mM NaCl in 20 mM Tris-HCl,
pH 8.0. Fractions containing mYfh1p were pooled
and concentrated to 1 ml, were diluted to 4 ml with
TN50, and were loaded on a UNO Q1 column (Bio-
Rad). The column was washed with 26 ml TN50, and
mYfh1p was eluted by a 40-ml linear NaCl gradient,
as described above. Fractions were pooled, concen-
trated to 1 ml, and loaded on a Superdex 200 column
(Pharmacia). Recombinant mYfh1p was eluted with
10 mM HEPES-KOH, pH 7.4, 100 mM NaCl. Frac-
tions were pooled, concentrated to 2.5 ml, and de-
salted into 10 mM HEPES-KOH, pH 7.4 (HEPES buf-
fer), through a NAP-25 column (Pharmacia); protein
aliquots (2 mg/ml) were stored at 70C. All steps
were performed at 4C, with use of a BioLogic HR
Workstation (Bio-Rad). Microelectrospray ionization
mass spectrometry was performed on isolated mYfh1p
(36 mM) in 10 mM ammonium bicarbonate, by means
of direct infusion (3 ml/min) in a Finnigan-Mat 900
Mass Spectrometer, as described elsewhere (Veenstra
et al. 1998). Iron concentration was determined by
inductively coupled plasma emission spectroscopy
(ICP) on an Optima ICP (PE Biosystems) (Nixon et
al. 1986).
Gel Filtration
High-resolution columns (16 mm # 50 cm) were
packed with 100 ml Superdex 200 preparative grade
or Superose 6 (Pharmacia) and were equilibrated with
HEPES buffer, 100 mM NaCl. Blue Dextran 2000 (1
mg/ml) was used to estimate void volumes, and molec-
ular-weight (MW) standard mixtures were used for cal-
ibrations. Samples (1 ml) were loaded using a static loop
(1 ml) and were eluted with HEPES buffer, 100 mM
NaCl. Samples were prepared by incubating mYfh1p
with Fe(NH4)2(SO4)2 or other metals (Sigma) at the re-
quired concentrations in 1 ml HEPES buffer for 1 h at
30C. After centrifugation at 14,000# g for 5 min, the
supernatant was immediately applied to the column.
Iron Release
Isolated mYfh1p (120 mM) was incubated with
Fe(NH4)2(SO4)2 at an Fe:mYfh1p ratio of 30:1, and the
sample was passed through a NAP-25 column to remove
unbound iron and was divided into two aliquots. The
total iron content in the sample was determined by ICP.
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Buffer and stock solutions and Fe-mYfh1p were made
anaerobic by purging with oxygen-free (!0.5 ppm) argon
with the use of septa-sealed vials, and they were added,
by means of a gas-tight syringe, to an anaerobic 3-ml
quartz cell in a Cary 1 spectrophotometer (Richards et
al. 1996). First, the chelator a,a′-bipyridine (BIPY) was
added anaerobically, and the absorbance (A) was zeroed
at 520 nm, which is the wavelength maximum of
(Richards et al. 1996). The reaction was2Fe(BIPY)3
started by the anaerobic addition of Fe-mYfh1p (total
protein 240 mg), and A520 versus time (A520/time) was
measured until the absorbance reached a constant value.
An anaerobic solution of sodium dithionite in 100 mM
HEPES buffer, pH 7.4, was added at 30 min (final con-
centration 1 mM), and measurements of A520/time were
continued until a new constant value was reached. The
final concentrations of mYfh1p and BIPY were 6 mM
and 1 mM, respectively, and the extinction coefficient
of at 520 nm is much higher than that of2Fe(BIPY)3
iron-loaded mYfh1p (9,000 vs. 200 M1cm1 per mol
of iron). Therefore, the absorbances measured in this
experiment reflect formation of , providing2Fe(BIPY)3
an accurate measurement of the amount of iron released
from Fe-mYfh1p.
Sedimentation Equilibrium Analysis
Isolated mYfh1p (8 mM) was incubated with 320
mM Fe(NH4)2(SO4)2 as described in the Gel Filtration
section. The sample was centrifuged and was passed
through a NAP-25 column, and it was diluted, with
HEPES buffer, to A280 p ∼0.3. Samples in aluminum-
filled epon (double-sector) centerpieces were layered
over perfluorohexane to a fluid height of 5–6 mm (0.2
ml). After 2 h at 18,000 rpm, the samples were cen-
trifuged to equilibrium for 16 h at 6,000 rpm at 17C
in a Beckman Prep-Scanner analytical ultracentrifuge
(Williams et al. 1958). Cells were scanned with a 200-
mm slit and a bandpass filter of nm.280 10
Electron Microscopy and Atomic Force Microscopy
Isolated mYfh1p (40 mM)was incubated with 1.6mM
Fe(NH4)2(SO4)2 to a final Fe:mYfh1p ratio of 40:1, and
it was chromatographed through the Superdex 200 col-
umn as described in the Gel Filtration section. Fractions
corresponding to the 1.1-MDa form (fractions 3–5; see
fig. 2D) in 10 mM HEPES-KOH, pH 7.4, 100 mM
NaCl, were diluted with distilled water and were recon-
centrated, by use of an Ultrafree-4 cell (Millipore), to a
final mYfh1p concentration of 20 mM and a final iron
concentration of 1 mM in 0.02 mM HEPES-KOH, pH
7.4, 0.2 mM NaCl. An aliquot was visualized by neg-
ative staining with 0.5% uranyl acetate in a JEOL 1200
EX II microscope at 60 kV (primary magnification
#50,000). Another aliquot was placed on a grid and
was dried. With no additional preparation, this sample
was analyzed by electron microscopy (EM) and then by
atomic force microscopy (AFM) (Hansma and Hoh
1994). AFM imaging was performed using tappingmode
in air with 125-mm silicon TESP tips in a NanoScope III
MultiMode system (Digital Instruments). The tapping
frequency was 288.2 kHz, and the scanning frequency
was 1 Hz. AFM images were analyzed using Digital In-
struments NanoScope IIIa software. Three-dimensional
images were generated from topographic height infor-
mation and were illuminated from various angles.
In Vivo Studies
Yeast cells were grown in rich medium containing 2%
galactose to late log phase, and mitochondria were iso-
lated (Branda et al. 1999), were diluted to a protein
concentration of 5 mg/ml in 10 mM HEPES buffer con-
taining 1 tablet/100 ml of complete EDTA-free protease
inhibitors (Boehringer Mannheim) and 0.375 % Triton
X-100, and were incubated for 30 min on ice with oc-
casional agitation. This was followed by centrifugation
at 165,000 # g for 30 min at 4C to remove insoluble
material. The supernatant (total protein∼3mg) was con-
centrated to 1 ml by use of an Ultrafree-4 cell and was
directly applied to a Superdex 200 column. Ten fractions
(5 ml each) were collected, and 1.5-ml aliquots were
concentrated and were analyzed by western blotting us-
ing anti-Yfh1p antibody (Branda et al. 1999). In im-
munoprecipitation experiments, yeast cells were grown
as described above, except that the medium was sup-
plemented with 55FeCl3 to a final iron concentration of
0.4 mM. Mitochondria were isolated and detergent-ex-
tracted, and the supernatants (total cpm ∼1.5–2.7 #
106) were fractionated on the Superdex 200 column as
described above. The fractions were pretreated with 100
ml protein A-Sepharose (beads). After removal of the
beads, the supernatants were incubated with anti-Yfh1p
antibodies, and the immunocomplexes were precipitated
with an additional 100 ml protein A-Sepharose (I.P.). The
I.P. pellets were washed with 10 mM HEPES-KOH, pH
7.4, and 100 mM NaCl, after which the beads and the
I.P. pellets were resuspended in the same buffer and were
counted.
Results
Recombinant mYfh1p Is Isolated from Bacterial Cells
as a Soluble Iron-Free Monomer
Similar to most mitochondrial proteins, Yfh1p is in-
itially translated in the cytoplasm as a larger precursor
protein (Knight et al. 1998). The precursor is imported
into mitochondria and is processed to the mature form
(mYfh1p), in two sequential steps, by the mitochondrial-
processing peptidase (MPP) (Branda et al. 1999). We
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Figure 1 Production of recombinant mYfh1p. A, N-terminal radiosequencing of mYfh1p. Top, Two-step processing of Yfh1p by purified
MPP, with “p,” “i,” and “m” denoting the precursor, intermediate, and mature forms of Yfh1p, as analyzed by 12% SDS/PAGE (Branda et
al. 1999). A methionine residue (underlined) was substituted for valine 60 downstream of the predicted second MPP cleavage site to provide
a radioactive marker, and [35S]methionine-pYfh1p(V60M) precursor was incubated with recombinant yeast MPP (Branda et al. 1999). Processing
products were separated by SDS/PAGE, were electroblotted onto a polyvinylidene difluoride membrane, and were detected by autoradiography.
The mYfh1p band was excised and applied directly on a PE/ABD Procise 494-HS sequencer, and 100% of each fraction was collected and was
analyzed by scintillation counting (Matsudaira 1987). Valine 52 marks the N-terminus of mYfh1p, as determined by the release of [35S]methionine
in cycle 9; note that, in the following cycles, the cpm decreased by ∼50% until reaching the level of background measured before cycle 9, as
a result of insufficient washing of the cartridge and the line to the fraction collector. The identified cleavage site, RFfVE, matches the consensus,
Rxf(S/x), found at many MPP cleavage sites (Gavel and von Heijne 1990). B, Overexpression and purification of mYfh1p. Aliquots of different
fractions were analyzed by 12% SDS/PAGE and SYPRO Orange (Molecular Probes) staining. MW p MW marker proteins (1 mg protein/
band). Lanes 1–2 show bacterial lysate (20 mg) before and after induction, respectively; lane 3, Macro-Prep DEAE pool (9 mg); lane 4, UNO
Q1 pool (4.5 mg); and lane 5, Superdex 200 pool (4 mg).C, IsolatedmYfh1pmaintains iron in a soluble form. A 320-mMsolutionof Fe(NH4)2(SO4)2
in 10 mM HEPES-KOH, pH 7.4, was incubated for 1 h at 30C in the absence or presence of 8 mM mYfh1p. Both samples were centrifuged
at 14,000 # g for 5 min, and the supernatants were removed before photography.
determined the N-terminus of mYfh1p by means of in
vitro processing with purified MPP and radiosequencing
(fig. 1A), expressed a recombinant mYfh1p protein in
E. coli, and purified it to homogeneity in three steps (fig.
1B). The purified protein migrated on SDS/PAGE with
an apparent MW of ∼20,000 (fig. 1B), an MW that was
higher than the predicted MW of ∼14,000. This abnor-
mal mobility was previously reported by Knight et al.
(1998) and Branda et al. (1999) and is explained by the
acidic nature of the protein (calculated isoelectric point
4.34). Similarly, purified mYfh1p was eluted from a Su-
perdex 200 column with an apparent MW of ∼18,000
(fig. 2A). Microelectrospray ionization mass spectrom-
etry of the purified protein, however, revealed a pre-
dominant (195%) ion species with an MW of 13,783,
an MW that precisely corresponds to the calculatedMW
of recombinant mYfh1p. ICP spectroscopy of the pu-
rified protein detected only background levels of iron.
Isolated mYfh1p is therefore a soluble monomer that
contains essentially no iron.
Iron Induces a High-MW Soluble Form of mYfh1p
To test whether iron can influence the behavior of
mYfh1p, we incubated 320 mM Fe(NH4)2(SO4)2 at neu-
tral pH under aerobic conditions in the absence or pres-
ence of isolated mYfh1p (8 mM; Fe:mYfh1p ratio 40:1).
Both samples turned yellow, indicating oxidation of Fe2
to Fe3. A large ferric oxyhydroxide precipitate formed
in the first sample, but there was no detectable protein
or iron precipitation in the sample containing mYfh1p
(fig. 1C). We subsequently incubated mYfh1p (8 mM)
with either Fe(NH4)2(SO4)2 (320 mM) or different di-
valent cations (320 mM), and we analyzed these samples
by means of gel filtration on a Superdex 200 column
(fractionation range 10–600 kDa). Whereas monomer
was detected in the absence of added metals (fig. 2A,
peak 1), incubation of mYfh1p with Fe(NH4)2(SO4)2
yielded a high-MW species (fig. 2C, peak 2) that ex-
ceeded the size range of the column. Peak 2 exhibited a
6-fold increase in A280 relative to peak 1; the absorbance
of ferric oxides ( M1cm1) in peak 2e p 160,000280
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Figure 2 Iron induces self-assembly of mYfh1p. A, Purified mYfh1p (total protein 110 mg; final concentration 8 mM) was incubated in
a final volume of 1 ml HEPES buffer for 1 h at 30C, and the sample was centrifuged at 14,000 # g for 5 min and was immediately applied
to a Superdex 200 column. V0 p void volume. The elution profile of isolated mYfh1p is superimposed on that of MW standards (broken line).
V p vitamin B12 (1.4 kDa); M p myoglobin (17 kDa); O p ovalbumin (44 kDa); G p gammaglobulin (158 kDa); T p thyroglobulin (669
kDa). B, Conditions were the same as those described for panel A, except that mYfh1p was incubated in the presence of 320 mM CaCl2, CoCl2,
MgCl2, or MnCl2. The four chromatograms are superimposed. The A280 scale is shown only for the top chromatogram. C, Conditions were
the same as those described for panel A, except that the incubation step was performed in the presence of 320 mM Fe(NH4)2(SO4)2. Note that
most of the A280 of peak 2 is accounted for by the absorbance of ferric oxides ( M
1 cm1), rather than the absorbance of mYfh1pe p 160,000280
( M1 cm1). D, Conditions were the same as those described for panel C, except that 440 mg total protein (final concentratione p 20,000280
8 mM) were used; the relevant portion of the chromatogram is shown (top). Middle, Protein concentration in the eluted fractions was analyzed
by 12% SDS/PAGE, followed by staining with SYPRO Orange and densitometry in a Storm 840 Optical Scanner using the ImageQuant software
package (Molecular Dynamics); a known amount (as determined by quantitative amino acid analysis) of purified mYfh1p was used as the
internal standard. Bottom, Iron concentration was determined in the eluted fractions by ICP.
accounts for this increase. One possible explanation for
this result is that, at neutral pH, the acidic nature of
mYfh1p makes it prone to interact with ferric oxides,
leading to formation of nonspecific aggregates.However,
fractions corresponding to peak 2 could be stored at
different temperatures (23C or 4C) for several days,
or they could be concentrated to at least 1.5 mg protein
per ml without any obvious protein or iron precipitation,
demonstrating a degree of solubility uncharacteristic of
nonspecific aggregates. Thus, an alternative explanation
is that peak 2 reflects a controlled assembly process. This
process was specifically induced by iron, because
mYfh1p did not show any tendency to self-associate
upon incubation with 320 mM CaCl2, CoCl2, MgCl2, or
MnCl2 (fig. 2B). In addition, peak 2 did not form in the
presence of 6 M urea or anti-Yfh1p antibodies (data not
shown).
Stepwise Assembly of mYfh1p
To distinguish between aggregation and a specific as-
sembly process, a larger amount of mYfh1p was incu-
bated with Fe(NH4)2(SO4)2 (Fe:mYfh1p ratio 40:1), and
the sample was analyzed on the Superdex 200 column
(fig. 2D). Under these conditions, we detected peak 2,
but we also detected monomer (peak 1) and an inter-
mediate peak corresponding to an MW of ∼93,000
(peak 3) (fig. 2D, top). The results of SDS/PAGE and
ICP analysis showed that most input mYfh1p (195%)
was recovered in fractions 1–30, along with 50% (35
mg) of the input iron. Of the input mYfh1p, ∼70% was
assembled into higher-MW species (fractions 1–26),with
peak 2 and peak 3 representing the predominant forms
(fig. 2D, middle), whereas ∼30% of the input mYfh1p
was eluted as monomer (fractions 27–29). Contrary to
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Figure 3 Iron-dependent stepwise assembly of mYfh1p. A, Fixed amount of mYfh1p (final concentration 120 mM [15-fold higher than
that which was used in fig. 2C–D]) was incubated with increasing concentrations of Fe(NH4)2(SO4)2 to obtain the Fe:mYfh1p ratios indicated.
Each sample was separately analyzed on the Superdex 200 column. B, As described for panel A, except that two different concentrations of
mYfh1p were used.
what might be expected from a nonspecific aggregation
process, the iron distribution among these three species
was not a function of the protein concentration. Peak 1
(fractions 27–29) showed a protein concentration of
1.7–2.5 mM and 0.4 atoms of iron per molecule of
mYfh1p (fig. 2D, bottom). Peak 3 (fractions 18–20) and
peak 2 (fractions 3–5) showed very similar protein con-
centrations (0.6–1.3 and 0.7–1.8 mM, corresponding to
∼14% and 15% of the input protein, respectively) (fig.
2D, middle), but they showed a 30-fold difference in
iron content (1.8–2.7 vs. 50–100 mM, corresponding to
∼1% and 26% of the input iron, respectively) (fig. 2D,
bottom). These data are consistent with a stepwise as-
sembly process that increases the iron-binding capacity
of mYfh1p without a concomitant increase in the ab-
solute protein concentration. A specific assembly process
is also supported by the inability of 30% of the input
mYfh1p to form higher-order species. A fraction of iron-
free monomer was consistently observed in independent
assembly reactions and with different protein prepara-
tions, and this may reflect a protein fold that is not
compatible with assembly.
Stepwise Assembly of mYfh1p Depends on the Molar
Fe:mYfh1p Ratio
A fixed amount of mYfh1p (final concentration 120
mM) was treated with increasing concentrations of
Fe(NH4)2(SO4)2 and was analyzed on the Superdex 200
column. Protein concentration was increased 15-fold,
compared with that in the experiments shown in figure
2, to enable determination of the protein concentration
in Superdex 200 fractions by means of amino acid anal-
ysis (fig. 3A). At an Fe:mYfh1p ratio of 1:1, we detected
only the monomer (peak 1; MW ∼18,000; a) and a
second species (peak 2; MW ∼50,000) that may corre-
spond to the mYfh1p trimer ( ). Increasingly largera3
species were detected at ratios of 4:1 (peak 3; MW
∼93,000; ), 7:1 (peak 4; MW ∼178,000; ), 10:1a a6 12
(peak 5; MW ∼331,000; ), and 20:1 (peak 6; MWa24
1600,000; this species corresponds to peak 2 in fig. 2D
and is denoted as on the basis of the results of anal-a60
yses described in the mYfh1p Assembles into Homo-
geneous Multimers of ∼1.1 MDa section). The intensity
of peak 1 decreased at Fe:mYfh1p ratios of 1:1–7:1, but
it did not decrease any further at higher ratios (fig. 3A),
a finding that is consistent with a fraction of monomer
that is not competent for assembly, as noted in figure
2D. These data suggest that there is an initial step, in
which an increasing fraction of monomer is assembled
into , and a subsequent step, in whicha r a r a3 6 12
is assembled into without any further monomera a12 60
contribution. We repeated this experiment three times
and obtained virtually identical chromatograms, a result
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Table 1










1 7:1 3.48a .36–0.71 .1–.2
2 4:1 2.83–3.92 13.21–15.88 3.7–4.9
3 4:1 1.60–2.10 11.61–15.89 6.4–8.0
4 7:1 2.39–2.61 29.82–30.63 11.4–12.8
5 10:1 2.54–3.19 49.64–58.57 15.6–22.4
6 20:1 1.70–2.43b 87.50–101.78 41.9–51.5
NOTE.—Fractions corresponding to the maxima of peaks 1–6
(shown in fig. 3A) were analyzed for protein and iron concentrations,
by means of amino acid analysis and ICP, and the final Fe:mYfh1p
ratio was calculated for each sample. The ranges of values measured
in three independent experiments are shown, except where indicated
by footnotes a and b. Note that peak 1 was analyzed at the input
ratio of 7:1 and contained only background levels of iron.
a .np 1
b .np 2
Figure 4 Iron release from mYfh1p. A, Chelator BIPY was
loaded anaerobically into a Cary 1 spectrophotometer, and the ab-
sorbance was zeroed at 520 nm (left arrow). The reaction was started
by anaerobic addition of Fe-mYfh1p (middle arrow [at 10 min]), and
A520/time was measured until the absorbance reached a constant value.
An anaerobic solution of sodium dithionite was added at 30 min (right
arrow), and measurements of A520/time were continued until a new
constant value was reached. B, Immediately afterward, the untreated
and BIPY/dithionite-treated aliquots (80 mg total protein each) were
separately analyzed on the Superdex 200 column.
indicating that stepwise assembly of mYfh1p is repro-
ducible. In figure 3B, two different concentrations of
mYfh1p (8 and 120 mM) were analyzed at an Fe:mYf1p
ratio of 1:1. Both samples showed only monomer (peak
1) and trimer (peak 2). Furthermore, assembly of a60
required a ratio 120:1 at 120 mM mYfh1p, a ratio that
is only two times lower than the 40:1 ratio required at
8 mM mYfh1p (fig. 2D). These data indicate that
mYfh1p assembly depends on the molar Fe:mYfh1p ra-
tio and not the absolute protein or iron concentration.
To determine the Fe:mYfh1p content of the species in
figure 3A, fractions corresponding to the peak maxima
were subjected to amino acid analysis and ICP. The data
in table 1 show that each peak was characterized by a
certain Fe:mYfh1p content, with little variability among
experiments. As already noted for peak 2 and peak 3
(see fig. 2D), the species in figure 3A showed similar
protein concentrations but increasingly higher iron con-
centrations, consistent with structural changes that ex-
pand the iron-loading capacity of mYfh1p. The largest
species (peak 6; ) contained 42–51 iron atoms pera60
molecule of mYfh1p, corresponding to 13,000 atoms of
iron per multimer.
mYfh1p Stores Iron in an Available Form
To define what form of iron is sequestered bymYfh1p,
we analyzed the electronic spectra of Superdex 200 frac-
tions corresponding to . These samples exhibiteda60
broad UV/visible spectra (220–570 nm) with intense ab-
sorptions characteristic of oxo-to-metal charge transfer
bands ( –1,600 M1cm1 ande p 3,600 e p330390 455515
–220 M1cm1 per mol of iron), characteristic of550
oxo-bridged ferric iron (Sanders-Loehr 1989). In agree-
ment with this finding, low-temperature (3.0–150 K)
electron paramagnetic-resonance (EPR) spectra of the
same samples were devoid of resonances that can be
assigned to mononuclear high-spin Fe3 species—that is,
is EPR-silent over this temperature range, despite thea60
presence of highly paramagnetic ferric ions. These data
are consistent with the presence of antiferromagnetically
coupled ferric iron pairs, such as those are found in the
iron core of ferritin (Chasteen et al. 1985). To analyze
whether this iron can be released from mYfh1p, isolated
protein (120 mM) was incubated with Fe(NH4)2(SO4)2
at an Fe:mYfh1p ratio of 30:1, which yields primarily
and monomer. In one-half of this sample, iron releasea60
was measured by successive addition of a specific Fe2
chelator (BIPY) and the reducing agent dithionite under
anaerobic conditions (Richards et al. 1996). We ob-
served two consecutive iron-release reactions (fig. 4A)
corresponding to the release of 40% and 60%, respec-
tively, of the total iron in the sample. This result is con-
sistent with the presence of a smaller group of readily
released Fe2 ions, which can be chelated by BIPY, and
a larger group of Fe3 ions, which can be chelated by
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Figure 5 Gel filtration and sedimentation equilibrium analyses
of Fe-mYfh1p. A, Experimental conditions were the same as those
described in the legend for figure 2C, except that the sample was
applied to a Superose 6 column. The elution profile of mYfh1p (un-
broken line) is superimposed on that of MW standards (broken line).
A p aldolase (158 kDa); C p catalase (232 kDa); F p ferritin (440
kDa); Tp thyroglobulin (669 kDa); Dp blue dextran 2,000 (2MDa).
B, Isolated mYfh1p was incubated with Fe(NH4)2(SO4)2, and the sam-
ple was subjected to sedimentation equilibrium analysis as described
in the Material and Methods section. The plot of log A280 versus is
2r
shown. The presence of at least two different macromolecular species
(multimer [m] and hexamer [h]) is deduced from two linear-fit lines.
The slopes correspond to and2(d logA ) / [d (r )] mp 1.64 hp280
. The equation #2 20.08 (2RT) / [(1 nr) ] [2.303(d logA )]/ [d (r )]¯ 280
(Williams et al. 1958) was used to calculate the MW of the multimer
and the hexamer. cm3/g, calculated from the amino acidnp 0.73¯
composition of mYfh1p, was used for h, and cm3/g, includingnp 0.58¯
also 50 equivalents of FeO, was used for m. C, The molecular mass
was also calculated at 22 different log A280/r
2 increments (blackened
circles in panel B) and was plotted versus the averaged A280/ml. The
m form, which accounts for ∼75% of the total A280, is denoted by the
six blackened symbols at 1.1 MDa, and the h form, which accounts
for ∼8% of the A280, is denoted by the cluster of blackened symbols
at 0.1 MDa.
BIPY only after reduction by dithionite. The two halves
of the assembly mixture—before and after BIPY/dithion-
ite treatment—were analyzed on the Superdex 200 col-
umn (fig. 4B). Peak 6 was the predominant species in
the first aliquot, but it was no longer detected in the
BIPY/dithionite-treated aliquot, which contained only
monomer (peak 1; ∼50%), trimer (peak 2; ∼30%), and
hexamer (peak 3; ∼20%). On the basis of the Fe:mYfh1p
content characteristic of peak 2 (∼4 Fe/mYfh1p), peak
3 (∼7 Fe/mYfh1p), and peak 6 (∼50 Fe/mYfh1p) (table
1), we calculated that !5% of the iron was still bound
to mYfh1p after BIPY/dithionite treatment, consistent
with the degree of iron release determined in figure 4A.
These data demonstrate that iron is stored in an available
form in mYfh1p multimers and that self-assembly of
mYfh1p is a reversible process.
mYfh1p Assembles into Homogeneous Multimers of
∼1.1. MDa
To measure the MW of the iron-bound forms of
mYfh1p, purified protein (8 mM) was incubated with
Fe(NH4)2(SO4)2 (Fe:mYfh1p ratio 40:1), and the sample
was applied to a Superose 6 column (fractionation range
5–5,000 kDa) (fig. 5A). The chromatogram showed a
major peak with an apparent MW of ∼1,000,000 (peak
1) and a smaller peak with an apparent MW of
∼100,000 (peak 2). Peak 1 was symmetrical and within
the fractionation range of the column, but it spanned a
wide size range, suggesting heterogeneity of the iron-
bearing species. A similar assembly reaction was sub-
sequently examined by analytical ultracentrifugation
(fig. 5B and C). At sedimentation equilibrium, the plot
of log A280 versus r
2 revealed two distinct slopes (fig. 5B)
corresponding to two main species of ∼1.1 MDa and
∼96 kDa, close to the apparent MW of peak 1 and peak
2 in figure 5A. The two species accounted for 75% and
8%, respectively, of the A280 loaded in the ultracentri-
fugation cell, whereas the remaining 17% was distrib-
uted over a range of masses from 0.2–0.8 MDa (fig. 5C),
consistent with the size range spanned by peak 1 (fig.
5A). Together with the data shown in fig. 2D, these
results indicate that, under the experimental conditions
used in these experiments, the mYfh1p monomer assem-
bles into two predominant forms of ∼1.1MDa and ∼100
kDa, corresponding to ∼60 and ∼6 mYfh1p subunits
per macromolecule, respectively. Results of analytical ul-
tracentrifugation of isolated Superdex 200 fractions cor-
responding to (fig. 2D; fractions 3–5) confirmed thea60
presence of a homogeneous species with an MW of
∼1,100,000 (not shown).
The ∼1.1-MDa Multimer Is a Regular Spherical Particle
For direct visualization of the 1.1-MDa species, Su-
perdex 200 fractions corresponding to were analyzeda60
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Figure 6 Electron microscopy of isolated Fe-mYfh1p multimers. Multimers were prepared and were isolated by gel filtration as described
in the Material and Methods section. Aliquots were subjected to negative staining with 0.5% uranyl acetate (A and B), or they were simply
dried on a grid and analyzed without further preparation (C and D). The initial magnification was #50,000. In panels A and C, the bar p
100 nm, whereas in panels B and D, the bar p 10 nm.
by EM and AFM. Electron micrographs of samples sub-
jected to negative staining showed a homogeneous prep-
aration of nearly circular particles (fig. 6A). By manually
measuring the diameter of 1150 particles, we obtained
a range of values from 13–19 nm, with most (70%) of
the particles ranging from 14.5–16 nm. Similar particles
were observed in total assembly mixtures that had not
been fractionated through the Superdex 200 column; no
particles were detected in electron micrographs of iso-
lated mYfh1p monomers (not shown). Individual par-
ticles appear to consist of an electron-dense ring sur-
rounding an apparently empty cavity (fig. 6B). A concern
regarding the use of this visualization method is that the
negative staining procedure may result in artifacts. To
exclude this possibility, a sample was placed onto a grid,
air-dried, and imaged without further preparation. Elec-
tron micrographs of this sample showed circular elec-
tron-transparent particles that were similar to those
viewed by negative staining (fig. 6C). The boundaries of
individual particles were defined by small electron-dense
granules (fig. 6D). The EM images shown in figure 6A–D
suggest that the 1.1-MDa species identified by gel filtra-
tion and analytical ultracentrifugation is a spherical
macromolecule. They also suggest that the iron associ-
ated with the 1.1-MDa species is in a dispersed form
and that it concentrates at the periphery of the macro-
molecule. To obtain a tridimensional profile, the sample
shown in figure 6C and D was also viewed by AFM. A
large-scale AFM image is shown in figure 7A, and three-
dimensional reconstructions are shown in figure 7B and
C. Particles above a 5-nm threshold above the surface
were counted, and the mean maximum height and full
width at half height were determined. From analysis of
1,392 particles, we obtained a peak height of 12.8
nm and a full width of nm. Vertical2.1 19.7 13.4
measurement from the AFM is the most accurate and
sensitive, particularly for analysis of particles whose size
is in the order of the radius of curvature of the AFM
tip (∼10 nm)—a condition that is known to cause
spreading of the horizontal measurement (Radmacher et
al. 1994). The mean peak height was in the order of the
average diameter obtained by measuring particles visu-
alized by negative staining and EM (fig. 6A). Thus, EM
and AFM indicate that the ∼1.1 MDa multimer is a
regular spherical particle.
Detection of Fe-Yfh1p Complexes in Yeast
Mitochondria
A detergent extract of wild-type yeast mitochondria
was fractionated on the Superdex 200 column. Ten
fractions (5 ml each) were collected, and the distri-
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Figure 7 AFM of isolated Fe-mYfh1p multimers. The sample
analyzed in figure 6C and D was viewed by AFM as described in the
Material and Methods section. A, AFM image over an area of 5 #
5 mm. The height range is indicated by the inset. Three-dimensional
AFM reconstruction from the top (B) and from a pitch angle of 33
degrees (C) are shown, and the procedure for measurement of width
and height is illustrated by the profile of one particle (C, inset).
bution of endogenous mYfh1p was analyzed by west-
ern blotting (fig. 8A). Native mYfh1p was eluted in
two peaks, with elution volumes corresponding to the
monomer (fraction 8–9) and a higher species with
MW 1600,000 (fraction 1). As a control, the
membrane was reprobed with an antibody against the
b-subunit of MPP, a matrix-localized heterodimer
consisting of one a-subunit (MW ∼52,000), and one
b-subunit (MW ∼50,000) (Fenton and Kalousek
1996). A single protein peak was eluted in this case,
with a peak maximum at ∼100 kDa (fig. 8A, fraction
5), as was expected for the MPP holoenzyme. The
distribution of endogenous mYfh1p was also analyzed
in an Atm1-deficient strain (atm1D) that accumulates
mitochondrial iron at levels 10 times higher than
the wild-type yeast (Kispal et al. 1997). Compared
with the wild type, the monomer was decreased by
∼50% (fig. 8A, fractions 8–9), and a larger proportion
of mYfh1p was shifted to higher-MW species (frac-
tions 1–7).
To analyze whether mYfh1p binds iron in vivo, mi-
tochondria were prepared from atm1D cells grown in
the presence of 55Fe; as a result of low uptake of 55Fe,
this analysis was not performed in wild-type yeast. Mi-
tochondrial extracts from atm1D cells were fractionat-
ed on the Superdex 200 column as described above. In
three independent experiments, 25% of the added 55Fe
was accumulated in mitochondria (0.05 mmol), where it
partitioned (1:4) between the soluble and insoluble
membrane fractions. The soluble mitochondrial fraction
was fractionated on the Superdex 200 column as de-
scribed above, and 5-ml fractions were collected. The
relative amounts of 55Fe recovered in fractions 1–10were
very similar in three independent experiments, withmost
counts recovered in fractions 1, 5, and 6 (fig. 8B); this
finding may reflect the presence of different iron-binding
molecules in these three fractions. All fractions were in-
itially incubated for 1 h with 100 ml proteinA-Sepharose,
to remove any 55Fe that would nonspecifically bind to
protein A or the Sepharose beads. This treatment was
followed by immunoprecipitation with anti-Yfh1p an-
tibodies and protein A-Sepharose. Significant levels of
55Fe were recovered only in the immunocomplexes pre-
cipitated from fraction 1 (fig. 8C), which is the fraction
that contains the high-MW form of mYfh1p (fig. 8A,
fraction 1). In contrast, there was no significant recovery
of 55Fe in the immunocomplexes precipitated from the
other fractions (fig. 8C). The 55Fe associated with the
immunoprecipitated high-MW form of mYfh1p repre-
sented 0.3% of the total (soluble plus insoluble) mito-
chondrial 55Fe and 6% of the soluble mitochondrial 55Fe.
This value is significant, considering that atm1D mito-
chondria contain 110 times more iron than wild-type
mitochondria (Kispal et al. 1997) and that the expression
levels of mYfh1p were not increased in atm1D, com-
pared with wild-type cells (fig. 8A). Estimates of the
concentration of 55Fe associated with the immunocom-
plexes from fraction 1 and the concentration of mYfh1p
in this fraction yielded a molar Fe:mYfh1p ratio of ∼16:
1. The presence of both 55Fe and nonradioactive iron in
the immunoprecipitated complexes may explain why
this ratio is lower than the ratio calculated for in vi-
tro–assembled multimers (table 1). The lower ratio may
also reflect the presence, in fraction 1, of species smaller
than (e.g., , which has an Fe:mYfh1p ratio closea a60 24
to 16:1; see table 1), and experimental error may also
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Figure 8 Detection of high-MW Fe-mYfh1p in vivo. A, Detergent extracts of isolated wild-type or atm1D mitochondria (∼3 mg total
protein in each case) were fractionated on a Superdex 200 column, and the eluted fractions were analyzed by western blotting. After detection
of mYfh1p, the wild-type membrane was reprobed with a polyclonal antibody against b-MPP. B and C, Mitochondrial extracts were prepared
from atm1D cells grown in the presence of 55FeCl3 and were fractionated on a Superdex 200 column as described above. B, The cpm of each
fraction were measured by scintillation counting and expressed as the percentage of the total cpm recovered in the 10 fractions analyzed
( cpm); the bars denote the means  SD of three experiments. C, Fractions were pretreated with 100 ml protein A-Sepharose60.8 1.6# 10
(beads), after which the supernatants (after removal of the beads) were incubated with anti-Yfh1p antibodies and immunocomplexes precipitated
with another 100 ml protein A-Sepharose (I.P.). The cpm associated with the beads and I.P. pellets are expressed as the percentage of the total
cpm in the corresponding fraction. The mean  SD of three experiments is shown.
play a role. These results are consistent with the presence
of high-MW Fe-mYfh1p in vivo.
Discussion
We have described the iron-dependent self-assembly of
recombinant yeast frataxin (mYfh1p). Whereas isolated
mYfh1p monomers contain no iron and show no sig-
nificant tendency to self-associate, addition of ferrous
iron to isolated mYfh1p results in the assembly of an
∼1.1-MDa multimer that can sequester 13,000 atoms of
iron in a soluble, stable, and available form. The pos-
sibility that this phenomenon arises from nonspecific ag-
gregation has been excluded on the basis of the results
of four different sets of experiments. We have shown
that mYfh1p self-assembly is specifically induced by
Fe2, whereas other divalent cations have no effect. Self-
assembly of mYfh1p is a titratable process that depends
on the molar Fe:mYfh1p ratio and not the absolute iron
or protein concentration. This process yields regular
multimers of reproducible iron:protein content, homo-
geneous molecular mass, and spherical shape. Iron can
be mobilized from these multimers, and iron release re-
sults in multimer disassembly. The presence of a high-
MW form of Fe-mYfh1p in isolated yeast mitochondria
indicates that this process most likely reflects the phys-
iological mechanism of yeast frataxin.
Probably the closest example to what we have ob-
served is the iron-storage protein ferritin (Harrison
and Arosio 1996). Ferritin monomers spontaneously
assemble into a 24-subunit hollow multimer capable
of storing up to 4,500 atoms of iron as a mineral core
in its cavity (Harrison and Arosio 1996). The main
apparent difference between ferritin and mYfh1p self-
assembly is that the former takes place in the absence
of iron (Harrison and Arosio 1996), whereas the lat-
ter is iron-dependent. In addition, the results of EM
of Fe-mYfh1p multimers and findings from iron-re-
lease experiments suggest that the iron sequestered
by mYfh1p is in a more dispersed and readily avail-
able form than is the iron bound to ferritin, which is
generally difficult to mobilize in the absence of re-
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ductants (Harrison and Arosio 1996). Nevertheless,
the oxidation state of the iron stored in the mYfh1p
multimers suggests a potential similarity to the iron-
storage mechanism of ferritin. Electronic spectra and
EPR analysis of mYfh1p multimers show the presence
of oxo-bridged ferric iron, and, accordingly, iron-re-
lease experiments demonstrate that 60% of the se-
questered iron is in the Fe3 form. Oxo-bridged ferric
iron species are found in ferritin and other binuclear
iron proteins (Chasteen et al. 1985). Apo-ferritin
multimers store iron by binding Fe2 ions and by cat-
alyzing their aerobic oxidation to oxo- and hydroxo-
bridged ferric ions, which then polymerize inside the
ferritin cavity to form a polyiron oxohydroxo mineral
core (Chasteen et al. 1985; Harrison and Arosio
1996). We have found that self-assembly of isolated
mYfh1p is induced by iron supplemented as
Fe(NH4)2(SO4)2 or FeCl2, whereas addition of FeCl3
causes protein precipitation (unpublished data).
Therefore, we speculate that self-assembly is initiated
by Fe2 binding to mYfh1p and by its oxidation to Fe3,
leading to formation of polyiron oxohydroxo clusters
faster than formation of insoluble ferric oxyhydroxides.
Studies addressing ferroxidase activity and ability to
assemble under anaerobic conditions are under way to
test this hypothesis. Because we did not detect any iron
bound to mYfh1p monomers, we conclude that two or
more subunits must be involved in the initial Fe2 bind-
ing. The smallest iron-containing species that we de-
tected is the mYfh1p trimer, which is formed at Fe:
mYfh1p ratios of 1:1. The results of titration
experiments suggest a stepwise mechanism of mYfh1p
self-assembly, with the trimer representing the initial
assembly unit. Because the iron content of the multimer
(∼3,000 atoms) is 10-fold higher than the total iron
content of 20 trimers (∼300 atoms), the assembly pro-
cess must also involve some structural changes that ex-
pand the initial iron-loading capacity. Of interest, the
results of our iron-release experiments show that the
mYfh1p multimers contain not only Fe3 ions but, also,
a smaller population of Fe2 atoms. Reduced iron could
be bound in a hydrophobic environment within the pro-
tein where oxygen is not readily accessible. A similar
mechanism has been proposed to explain the ability of
the enzyme ferrochelatase to keep iron in a reduced
form, as is required for its attachment to protoporphy-
rin IX to yield heme (Romslo 1980). Thus, mYfh1p
multimers could stabilize ferrous iron via its oxidation
to oxo-bridged ferric species and, at the same time,
could maintain a smaller supply of Fe2 atoms.
The properties described above would be ideal for a
role of Yfh1p in mitochondrial iron management. Most
mitochondrial iron is normally bound in cytochromes
and iron-sulfur proteins in the inner and outer mem-
branes and to the iron-sulfur protein aconitase in the
matrix. A smaller fraction of nonheme non-FeS iron is
believed to represent the main source of bioavailable
iron inside mitochondria (Tangeras 1985). In rat liver
mitochondria, this fraction is distributed between the
inner membrane and the matrix, and it corresponds to
40% of the total mitochondrial iron (Tangeras 1985).
In our immunoprecipitation experiments, 6% of the sol-
uble mitochondrial 55Fe accumulated in atm1D mito-
chondria was associated with high-MW mYfh1p. Be-
cause atm1D mitochondria contain normal levels of
mYfh1p but accumulate 10 times more iron than do
wild-type mitochondria, the fraction of iron normally
bound to mYfh1p may be higher than we have deter-
mined. Similarly, the molar Fe:mYfh1p ratio in native
Fe-mYfh1p complexes is probably higher than the es-
timated ratio of 16:1, because this value takes into ac-
count only the radioactive iron atoms bound in the com-
plexes. Even though a precise determination of the Fe:
mYfh1p stoichiometry in vivo must await purification
of sufficient amounts of native complexes, the data sup-
port a model in which mYfh1p binds uncomplexed iron
and stores it in a bioavailable form.
This model may seem difficult to reconcile with ob-
servations that deletion of Yfh1p (yfh1D) results in mi-
tochondrial iron accumulation (Babcock et al. 1997;
Foury and Cazzalini 1997). The primary effect of Yfh1p
deletion, however, is a loss of mitochondrial iron export;
mitochondrial iron accumulation is a secondary effect
resulting from cytoplasmic iron starvation and induc-
tion of the plasma membrane high-affinity iron trans-
porter FET3 (Foury 1999; Radisky et al. 1999; Chen
and Kaplan 2000). Thus, the ability of recombinant
mYfh1p to bind iron and to maintain it in a soluble
and available form in vitro is consistent with the role
played by native Yfh1p in iron export and could also
account for a proposed role in iron-sulfur cluster bio-
synthesis (Foury 1999). The oxidative damage associ-
ated with frataxin deficiency in FRDA (Rotig et al.
1997; Bradley et al. 2000) implies that, in storing un-
complexed iron, Yfh1p should also prevent iron tox-
icity. We have found that, by complexing Fe2, recom-
binant mYfh1p inhibits hydroxyl radical formation
from Fenton chemistry (manuscript in preparation).
Thus, the iron-dependent self-assembly of mYfh1p in
vitro may reflect physiological roles in mitochondrial
iron bioavailability and protection from iron-induced
oxidative damage.
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